Your Specialized Oncology CRO as Strategic Advisor – Real World Evidence
Optimizing the partnership between Sponsors and CROs can move the relationship from a tactical client/vendor operating model to a more…
What to Look for When Selecting a CRO – Real World Evidence
There is a myriad of factors involved in selecting a CRO. Do CRO team members have the necessary therapeutic expertise?…
2018 in Retrospect – Real World Evidence of Win-Win CRO/Sponsor Relationships
What’s in Store for 2019 and Beyond? The Clinical Trials Market was valued at USD 32,700 million in 2017 and…
Real World Evidence of a Successful Oncology Trial Rescue in Canada
Each clinical study presents unique challenges, and it’s not unusual despite every effort that a clinical trial does not proceed…
How Does Your CRO’s Feasibility Process Contribute to Your Clinical Trial Success?
In clinical research, the process of finding and selecting sites is essential to the success of a study, as it…
Will Canada’s Multi-Center Approval Processes Help Your Oncology Clinical Trial Exceed Pivotal Milestones?
For the Sponsor choosing Canada to help meet and exceed pivotal corporate objectives on their oncology trial, First Site Opened…
Exploring a ‘Rescue’ Strategy for Your Oncology Clinical Trial?
Although not formally defined within the industry, the term ‘rescue’ is commonly linked with clinical trials where enrollment is falling…
Navigating Canadian Regulations for Oncology Clinical Research – Part II
Navigating Canadian Regulations for Oncology Clinical Research Your Questions Answered Part II Senior executives from oncology drug developers looking to…
20 Years of Unparalleled Canadian Oncology Clinical Research Experience
Scimega Research, Canada’s premier oncology contract research organization (CRO), was founded twenty years ago by two dynamic entrepreneurs, Denise Deakin…
Navigating Canadian Regulations for Oncology Clinical Research – Part I
Navigating Canadian Regulations for Oncology Clinical Research Your Questions Answered Part I Senior executives from oncology drug developers looking to…